Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Leslie Pires"'
Autor:
Jane Miller, Leslie Pires, Trevor Tejada-Berges, Mary E. Gordinier, Don S. Dizon, Robert D. Legare, Cornelius O. Granai, Paul DiSilvestro, Joanna Schwartz, Sherry Weitzen, Adam Rojan, Richard G. Moore
Publikováno v:
Gynecologic Oncology. 100:417-421
Although the standard of care for advanced epithelial ovarian cancer (EOC) is six cycles (6C) of platinum-taxane (PT), there have been no studies on the optimal duration of treatment in the era of adjuvant taxanes. At our center, some women receive e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de54bf74199f3cf75b2e2a3cbad68d2
https://doi.org/10.1016/j.ygyno.2005.10.031
https://doi.org/10.1016/j.ygyno.2005.10.031
Autor:
Paul DiSilvestro, Leslie Pires, Mary E. Gordinier, Adam Rojan, Robert D. Legare, Jane Miller, Joanna Schwartz, Cornelius O. Granai, Richard G. Moore, Don S. Dizon
Publikováno v:
Gynecologic Oncology. 100:149-151
Purpose. With the use of steroid premedication, the incidence of severe hypersensitivity reactions (S-HSR) to paclitaxel is estimated to be 2%. For those who develop a S-HSR to paclitaxel, docetaxel has been employed as an alternative agent though th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1743b4d66bd9553555312fc1a786db
https://doi.org/10.1016/j.ygyno.2005.08.004
https://doi.org/10.1016/j.ygyno.2005.08.004
Autor:
Adam Rojan, Robert D. Legare, Joanna Schwartz, Mary E. Gordinier, Don S. Dizon, Jane Miller, Leslie Pires, Richard G. Moore, Paul DiSilvestro, Cornelius O. Granai, Jennifer Gass
Publikováno v:
Journal of Clinical Oncology. 23:2052-2052
2052 Background: Taxanes are used to treat both breast and gynecologic cancers. The incidence of severe hypersensitivity reactions (S-HSR) to paclitaxel (P) is estimated to be 2% or lower, especially with the use of steroids and anti-histamines. For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bebe8deaf14c5fca2a1aaf28b1c9657
https://doi.org/10.1200/jco.2005.23.16_suppl.2052
https://doi.org/10.1200/jco.2005.23.16_suppl.2052